+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gadolinium Contrast Media Market - Global Forecast 2026-2032- Product Image
Gadolinium Contrast Media Market - Global Forecast 2026-2032- Product Image
Sale

Gadolinium Contrast Media Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6129141
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Gadolinium Contrast Media Market is projected to reach USD 4.16 Billion in 2026. It is expected to continue growing at a CAGR of 4.25%, reaching USD 5.32 Billion by 2032.

Gadolinium Contrast Media: Clinical Role and Strategic Context

Gadolinium contrast media enhance magnetic resonance imaging by improving visualization of vascular structures, lesions, inflammation, and tissue perfusion. Their use is shaped by diagnostic requirements, patient risk assessment, imaging protocols, regulatory oversight, and the availability of alternative techniques. Strategic priorities center on maintaining diagnostic value while strengthening safety controls, appropriate-use criteria, supply continuity, and responsible administration.

Safety, Sustainability, and Workflow Are Reshaping Gadolinium Use

The landscape is being transformed by greater attention to renal function, prior hypersensitivity reactions, cumulative exposure, and the use of macrocyclic or other agents with differing retention profiles. Imaging providers are also seeking more standardized protocols, efficient injection workflows, clearer documentation, and reduced repeat examinations. Environmental considerations are encouraging improvements in packaging, waste handling, procurement, and facility-level stewardship without compromising diagnostic performance.

Artificial Intelligence Is Improving Selection, Protocols, and Interpretation

Artificial intelligence is increasingly relevant across the gadolinium contrast workflow. Decision-support tools can help identify contraindications, reconcile clinical information, support patient screening, and recommend examination protocols. Image-processing systems may improve lesion conspicuity, motion correction, segmentation, and prioritization of examinations for review. Human oversight remains essential because algorithmic outputs require clinical validation, transparent governance, monitoring for bias, and compliance with medical-device requirements.

Regional Insights: Regulation and Access Create Distinct Operating Conditions

North America emphasizes evidence-based appropriateness, safety screening, hospital protocol standardization, and technology-enabled workflow management. Europe places strong weight on pharmacovigilance, coordinated regulation, environmental responsibility, and prudent use. Asia-Pacific combines rapid imaging-capacity development with varied reimbursement, regulatory, and infrastructure conditions. Latin America is shaped by uneven access to advanced imaging, public-private differences, procurement complexity, and the need for dependable distribution. The Middle East is investing in specialist healthcare capacity while focusing on centralized procurement, quality assurance, and workforce development. Africa faces greater variation in equipment availability, specialist expertise, and supply reliability, making training, maintenance, and sustainable access especially important.

Group Insights: Policy Alignment and Procurement Shape Adoption

ASEAN markets show the importance of interoperable standards, cross-border supply coordination, and differentiated approaches to healthcare access. BRICS members reflect diverse regulatory systems and healthcare infrastructures, with domestic manufacturing, affordability, and procurement resilience often prominent considerations. The European Union benefits from harmonized regulatory structures while retaining national differences in reimbursement and clinical implementation. G7 systems generally emphasize mature safety governance, advanced imaging infrastructure, and data-driven quality improvement. GCC countries are strengthening tertiary-care capabilities and centralized purchasing, while NATO members operate across varied healthcare systems but share interest in preparedness, interoperability, and resilient medical supply chains.

Country Insights: National Priorities Differ Across Major Imaging Systems

Australia emphasizes centralized health-system governance, rural access, and prudent imaging pathways. Brazil balances expanding diagnostic access with regulatory, reimbursement, and distribution complexity. Canada focuses on public-system capacity, regional equity, and standardized safety practices. China is advancing domestic healthcare capability while managing regulatory consistency and broad geographic demand. France, Germany, Italy, and Spain operate within European safety and quality frameworks but differ in procurement, reimbursement, and service delivery. India faces substantial variation between urban and rural imaging access and places importance on affordability and workforce development. Japan and South Korea combine sophisticated imaging ecosystems with strong quality expectations and aging-population needs. Mexico is expanding diagnostic capacity while addressing infrastructure and access disparities. Russia’s market environment is influenced by domestic supply considerations and healthcare-system resilience. The United Kingdom emphasizes evidence-based utilization, centralized guidance, and operational efficiency. The United States places strong emphasis on appropriateness, renal-risk screening, patient safety, and workflow optimization.

Action Priorities for Leaders in Gadolinium Contrast Media

Industry leaders should align product, clinical, and operational decisions with documented patient-safety evidence and local regulatory requirements. They should strengthen screening and administration protocols, support education for radiologists and technologists, and improve traceability across ordering, dispensing, injection, and follow-up. Partnerships with imaging providers can help validate workflow tools and artificial-intelligence applications in real clinical settings. Resilient sourcing, contingency planning, transparent environmental practices, and interoperable data systems can reduce operational vulnerability. Leaders should also distinguish clearly between clinical evidence, approved indications, and promotional claims when communicating with providers and patients.

Research Methodology: Evidence-Based Assessment of the Market Environment

This executive summary uses a structured qualitative assessment of the gadolinium contrast media landscape, organized around clinical use, safety, regulation, technology, workflow, sustainability, access, and healthcare-system conditions. Regional, group, and country perspectives are synthesized from the supplied geographic scope and established healthcare and regulatory considerations. The analysis deliberately excludes market estimates, market sizing, market shares, forecasts, and company-specific comparisons. Conclusions should be validated against current national labeling, professional guidance, regulatory communications, procurement rules, and institution-level protocols before operational decisions are made.

Conclusion: Responsible Innovation Will Define Future Diagnostic Use

Gadolinium contrast media remain closely linked to the quality and utility of contrast-enhanced magnetic resonance imaging, but their role is increasingly governed by safety stewardship, protocol discipline, regulatory scrutiny, and operational resilience. Regional and national differences will continue to influence access and implementation. Organizations that combine evidence-based patient selection, reliable supply practices, responsible technology adoption, workforce training, and transparent governance will be better positioned to preserve diagnostic value while addressing evolving clinical and societal expectations.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Gadolinium Contrast Media Market, by Product Type
7.1. Introduction
7.2. Ionic Linear
7.2.1. Gadopentetate Dimeglumine
7.2.2. Gadoxetate Disodium
7.3. Ionic Macrocyclic
7.4. Nonionic Linear
7.4.1. Gadodiamide
7.4.2. Gadoversetamide
7.5. Nonionic Macrocyclic
7.5.1. Gadobutrol
7.5.2. Gadoteridol
8. Gadolinium Contrast Media Market, by Form
8.1. Introduction
8.2. Powder For Injection
8.3. Solution For Injection
8.3.1. Multi Dose Vials
8.3.2. Single Dose Vials
9. Gadolinium Contrast Media Market, by Application
9.1. Introduction
9.2. Cardiovascular
9.2.1. Angiography
9.2.2. Cardiac Mri
9.3. Musculoskeletal
9.3.1. Joint Imaging
9.3.2. Soft Tissue Imaging
9.4. Neurology
9.4.1. Brain Mri
9.4.2. Spinal Mri
9.5. Oncology
9.5.1. Metastasis Detection
9.5.2. Tumor Delineation
10. Gadolinium Contrast Media Market, by End User
10.1. Introduction
10.2. Ambulatory Care Centers
10.2.1. Day Care Centers
10.2.2. Physician Offices
10.3. Diagnostic Imaging Centers
10.3.1. Clinic Based Centers
10.3.2. Standalone Centers
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
11. Gadolinium Contrast Media Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Gadolinium Contrast Media Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Gadolinium Contrast Media Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Bayer AG
15.2. Beijing Beilu Pharmaceutical Co., Ltd.
15.3. Bracco Imaging S.p.A.
15.4. Canon Medical Systems Corporation
15.5. Daiichi Sankyo Company, Ltd.
15.6. GE HealthCare Technologies Inc.
15.7. Guerbet S.A.
15.8. Hengrui Medicine
15.9. iThera Medical
15.10. J.B. Chemicals and Pharmaceuticals Ltd.
15.11. Jiangsu Hengrui Medicine Co., Ltd.
15.12. Lantheus Medical Imaging, Inc.
15.13. Mallinckrodt plc
15.14. Nanjing Jinling Pharmaceuticals
15.15. Nano Therapeutics Pvt. Ltd.
15.16. Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
15.17. Siemens Healthineers
15.18. Subhra Pharma Pvt. Ltd.
15.19. United Imaging Healthcare
15.20. Zhejiang Hisun Pharmaceutical Co., Ltd.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Gadolinium Contrast Media Market, Years Considered for the Study
FIGURE 2. Global Gadolinium Contrast Media Market, Research Design
FIGURE 3. Global Gadolinium Contrast Media Market, Research Framework
FIGURE 4. Global Gadolinium Contrast Media Market, Data Triangulation
FIGURE 5. Global Gadolinium Contrast Media Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Gadolinium Contrast Media Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Gadolinium Contrast Media Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Gadolinium Contrast Media Market Size, by Form, 2025 vs 2032 (%)
FIGURE 9. Global Gadolinium Contrast Media Market Size, by Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Gadolinium Contrast Media Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Gadolinium Contrast Media Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Gadolinium Contrast Media Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Gadolinium Contrast Media Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Gadolinium Contrast Media Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Gadolinium Contrast Media Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Gadolinium Contrast Media Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Gadolinium Contrast Media Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Gadolinium Contrast Media Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Gadolinium Contrast Media Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Gadolinium Contrast Media Market Segmentation & Coverage
TABLE 2. Global Gadolinium Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 3. Global Gadolinium Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Ionic Linear Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Ionic Linear Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Ionic Linear Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Gadopentetate Dimeglumine Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Gadopentetate Dimeglumine Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Gadopentetate Dimeglumine Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Gadoxetate Disodium Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Gadoxetate Disodium Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Gadoxetate Disodium Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Ionic Macrocyclic Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Ionic Macrocyclic Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Ionic Macrocyclic Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Nonionic Linear Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Nonionic Linear Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Nonionic Linear Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Gadodiamide Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Gadodiamide Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Gadodiamide Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Gadoversetamide Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Gadoversetamide Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Gadoversetamide Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Nonionic Macrocyclic Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Nonionic Macrocyclic Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Nonionic Macrocyclic Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Gadobutrol Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Gadobutrol Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Gadobutrol Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Gadoteridol Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Gadoteridol Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Gadoteridol Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Gadolinium Contrast Media Market Size, by Form, 2017-2032 (USD Million)
TABLE 35. Global Powder For Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Powder For Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Powder For Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Solution For Injection Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Solution For Injection Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Solution For Injection Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Multi Dose Vials Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Multi Dose Vials Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Multi Dose Vials Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Single Dose Vials Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Single Dose Vials Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Single Dose Vials Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Gadolinium Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 48. Global Cardiovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Cardiovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Cardiovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Angiography Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Angiography Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Angiography Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Cardiac Mri Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Cardiac Mri Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Cardiac Mri Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Musculoskeletal Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Musculoskeletal Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Musculoskeletal Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Joint Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Joint Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Joint Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Soft Tissue Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Soft Tissue Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Soft Tissue Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Brain Mri Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Brain Mri Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Brain Mri Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Spinal Mri Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Spinal Mri Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Spinal Mri Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Metastasis Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Metastasis Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Metastasis Detection Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Tumor Delineation Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Tumor Delineation Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Tumor Delineation Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Gadolinium Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 85. Global Ambulatory Care Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Ambulatory Care Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Ambulatory Care Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Day Care Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Day Care Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Day Care Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Physician Offices Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Physician Offices Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Physician Offices Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Diagnostic Imaging Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Diagnostic Imaging Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Diagnostic Imaging Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Clinic Based Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Clinic Based Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Clinic Based Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Standalone Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Standalone Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Standalone Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Gadolinium Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Gadolinium Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Gadolinium Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Gadolinium Contrast Media Market Size, by Ionic Linear, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Gadolinium Contrast Media Market Size, by Nonionic Linear, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Gadolinium Contrast Media Market Size, by Nonionic Macrocyclic, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Gadolinium Contrast Media Market Size, by Form, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Gadolinium Contrast Media Market Size, by Solution For Injection, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Gadolinium Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Gadolinium Contrast Media Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Gadolinium Contrast Media Market Size, by Musculoskeletal, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Gadolinium Contrast Media Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Gadolinium Contrast Media Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Gadolinium Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Gadolinium Contrast Media Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Gadolinium Contrast Media Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Gadolinium Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 129. North America Gadolinium Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. North America Gadolinium Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 131. North America Gadolinium Contrast Media Market Size, by Ionic Linear, 2017-2032 (USD Million)
TABLE 132. North America Gadolinium Contrast Media Market Size, by Nonionic Linear, 2017-2032 (USD Million)
TABLE 133. North America Gadolinium Contrast Media Market Size, by Nonionic Macrocyclic, 2017-2032 (USD Million)
TABLE 134. North America Gadolinium Contrast Media Market Size, by Form, 2017-2032 (USD Million)
TABLE 135. North America Gadolinium Contrast Media Market Size, by Solution For Injection, 2017-2032 (USD Million)
TABLE 136. North America Gadolinium Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 137. North America Gadolinium Contrast Media Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 138. North America Gadolinium Contrast Media Market Size, by Musculoskeletal, 2017-2032 (USD Million)
TABLE 139. North America Gadolinium Contrast Media Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 140. North America Gadolinium Contrast Media Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 141. North America Gadolinium Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. North America Gadolinium Contrast Media Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 143. North America Gadolinium Contrast Media Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 144. North America Gadolinium Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 145. Latin America Gadolinium Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Latin America Gadolinium Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 147. Latin America Gadolinium Contrast Media Market Size, by Ionic Linear, 2017-2032 (USD Million)
TABLE 148. Latin America Gadolinium Contrast Media Market Size, by Nonionic Linear, 2017-2032 (USD Million)
TABLE 149. Latin America Gadolinium Contrast Media Market Size, by Nonionic Macrocyclic, 2017-2032 (USD Million)
TABLE 150. Latin America Gadolinium Contrast Media Market Size, by Form, 2017-2032 (USD Million)
TABLE 151. Latin America Gadolinium Contrast Media Market Size, by Solution For Injection, 2017-2032 (USD Million)
TABLE 152. Latin America Gadolinium Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 153. Latin America Gadolinium Contrast Media Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 154. Latin America Gadolinium Contrast Media Market Size, by Musculoskeletal, 2017-2032 (USD Million)
TABLE 155. Latin America Gadolinium Contrast Media Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 156. Latin America Gadolinium Contrast Media Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 157. Latin America Gadolinium Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 158. Latin America Gadolinium Contrast Media Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 159. Latin America Gadolinium Contrast Media Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 160. Latin America Gadolinium Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 161. Europe Gadolinium Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 162. Europe Gadolinium Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 163. Europe Gadolinium Contrast Media Market Size, by Ionic Linear, 2017-2032 (USD Million)
TABLE 164. Europe Gadolinium Contrast Media Market Size, by Nonionic Linear, 2017-2032 (USD Million)
TABLE 165. Europe Gadolinium Contrast Media Market Size, by Nonionic Macrocyclic, 2017-2032 (USD Million)
TABLE 166. Europe Gadolinium Contrast Media Market Size, by Form, 2017-2032 (USD Million)
TABLE 167. Europe Gadolinium Contrast Media Market Size, by Solution For Injection, 2017-2032 (USD Million)
TABLE 168. Europe Gadolinium Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 169. Europe Gadolinium Contrast Media Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 170. Europe Gadolinium Contrast Media Market Size, by Musculoskeletal, 2017-2032 (USD Million)
TABLE 171. Europe Gadolinium Contrast Media Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 172. Europe Gadolinium Contrast Media Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 173. Europe Gadolinium Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. Europe Gadolinium Contrast Media Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 175. Europe Gadolinium Contrast Media Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 176. Europe Gadolinium Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 177. Middle East Gadolinium Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 178. Middle East Gadolinium Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 179. Middle East Gadolinium Contrast Media Market Size, by Ionic Linear, 2017-2032 (USD Million)
TABLE 180. Middle East Gadolinium Contrast Media Market Size, by Nonionic Linear, 2017-2032 (USD Million)
TABLE 181. Middle East Gadolinium Contrast Media Market Size, by Nonionic Macrocyclic, 2017-2032 (USD Million)
TABLE 182. Middle East Gadolinium Contrast Media Market Size, by Form, 2017-2032 (USD Million)
TABLE 183. Middle East Gadolinium Contrast Media Market Size, by Solution For Injection, 2017-2032 (USD Million)
TABLE 184. Middle East Gadolinium Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. Middle East Gadolinium Contrast Media Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 186. Middle East Gadolinium Contrast Media Market Size, by Musculoskeletal, 2017-2032 (USD Million)
TABLE 187. Middle East Gadolinium Contrast Media Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 188. Middle East Gadolinium Contrast Media Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 189. Middle East Gadolinium Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Middle East Gadolinium Contrast Media Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 191. Middle East Gadolinium Contrast Media Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 192. Middle East Gadolinium Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 193. Africa Gadolinium Contrast Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 194. Africa Gadolinium Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 195. Africa Gadolinium Contrast Media Market Size, by Ionic Linear, 2017-2032 (USD Million)
TABLE 196. Africa Gadolinium Contrast Media Market Size, by Nonionic Linear, 2017-2032 (USD Million)
TABLE 197. Africa Gadolinium Contrast Media Market Size, by Nonionic Macrocyclic, 2017-2032 (USD Million)
TABLE 198. Africa Gadolinium Contrast Media Market Size, by Form, 2017-2032 (USD Million)
TABLE 199. Africa Gadolinium Contrast Media Market Size, by Solution For Injection, 2017-2032 (USD Million)
TABLE 200. Africa Gadolinium Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 201. Africa Gadolinium Contrast Media Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 202. Africa Gadolinium Contrast Media Market Size, by Musculoskeletal, 2017-2032 (USD Million)
TABLE 203. Africa Gadolinium Contrast Media Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 204. Africa Gadolinium Contrast Media Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 205. Africa Gadolinium Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Africa Gadolinium Contrast Media Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 207. Africa Gadolinium Contrast Media Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 208. Africa Gadolinium Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 209. Global Gadolinium Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 210. ASEAN Gadolinium Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 211. ASEAN Gadolinium Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 212. ASEAN Gadolinium Contrast Media Market Size, by Ionic Linear, 2017-2032 (USD Million)
TABLE 213. ASEAN Gadolinium Contrast Media Market Size, by Nonionic Linear, 2017-2032 (USD Million)
TABLE 214. ASEAN Gadolinium Contrast Media Market Size, by Nonionic Macrocyclic, 2017-2032 (USD Million)
TABLE 215. ASEAN Gadolinium Contrast Media Market Size, by Form, 2017-2032 (USD Million)
TABLE 216. ASEAN Gadolinium Contrast Media Market Size, by Solution For Injection, 2017-2032 (USD Million)
TABLE 217. ASEAN Gadolinium Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 218. ASEAN Gadolinium Contrast Media Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 219. ASEAN Gadolinium Contrast Media Market Size, by Musculoskeletal, 2017-2032 (USD Million)
TABLE 220. ASEAN Gadolinium Contrast Media Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 221. ASEAN Gadolinium Contrast Media Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 222. ASEAN Gadolinium Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. ASEAN Gadolinium Contrast Media Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 224. ASEAN Gadolinium Contrast Media Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 225. ASEAN Gadolinium Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 226. GCC Gadolinium Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 227. GCC Gadolinium Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 228. GCC Gadolinium Contrast Media Market Size, by Ionic Linear, 2017-2032 (USD Million)
TABLE 229. GCC Gadolinium Contrast Media Market Size, by Nonionic Linear, 2017-2032 (USD Million)
TABLE 230. GCC Gadolinium Contrast Media Market Size, by Nonionic Macrocyclic, 2017-2032 (USD Million)
TABLE 231. GCC Gadolinium Contrast Media Market Size, by Form, 2017-2032 (USD Million)
TABLE 232. GCC Gadolinium Contrast Media Market Size, by Solution For Injection, 2017-2032 (USD Million)
TABLE 233. GCC Gadolinium Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. GCC Gadolinium Contrast Media Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 235. GCC Gadolinium Contrast Media Market Size, by Musculoskeletal, 2017-2032 (USD Million)
TABLE 236. GCC Gadolinium Contrast Media Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 237. GCC Gadolinium Contrast Media Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 238. GCC Gadolinium Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 239. GCC Gadolinium Contrast Media Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 240. GCC Gadolinium Contrast Media Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 241. GCC Gadolinium Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 242. European Union Gadolinium Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 243. European Union Gadolinium Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 244. European Union Gadolinium Contrast Media Market Size, by Ionic Linear, 2017-2032 (USD Million)
TABLE 245. European Union Gadolinium Contrast Media Market Size, by Nonionic Linear, 2017-2032 (USD Million)
TABLE 246. European Union Gadolinium Contrast Media Market Size, by Nonionic Macrocyclic, 2017-2032 (USD Million)
TABLE 247. European Union Gadolinium Contrast Media Market Size, by Form, 2017-2032 (USD Million)
TABLE 248. European Union Gadolinium Contrast Media Market Size, by Solution For Injection, 2017-2032 (USD Million)
TABLE 249. European Union Gadolinium Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 250. European Union Gadolinium Contrast Media Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 251. European Union Gadolinium Contrast Media Market Size, by Musculoskeletal, 2017-2032 (USD Million)
TABLE 252. European Union Gadolinium Contrast Media Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 253. European Union Gadolinium Contrast Media Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 254. European Union Gadolinium Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 255. European Union Gadolinium Contrast Media Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 256. European Union Gadolinium Contrast Media Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 257. European Union Gadolinium Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 258. BRICS Gadolinium Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 259. BRICS Gadolinium Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 260. BRICS Gadolinium Contrast Media Market Size, by Ionic Linear, 2017-2032 (USD Million)
TABLE 261. BRICS Gadolinium Contrast Media Market Size, by Nonionic Linear, 2017-2032 (USD Million)
TABLE 262. BRICS Gadolinium Contrast Media Market Size, by Nonionic Macrocyclic, 2017-2032 (USD Million)
TABLE 263. BRICS Gadolinium Contrast Media Market Size, by Form, 2017-2032 (USD Million)
TABLE 264. BRICS Gadolinium Contrast Media Market Size, by Solution For Injection, 2017-2032 (USD Million)
TABLE 265. BRICS Gadolinium Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. BRICS Gadolinium Contrast Media Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 267. BRICS Gadolinium Contrast Media Market Size, by Musculoskeletal, 2017-2032 (USD Million)
TABLE 268. BRICS Gadolinium Contrast Media Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 269. BRICS Gadolinium Contrast Media Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 270. BRICS Gadolinium Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 271. BRICS Gadolinium Contrast Media Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 272. BRICS Gadolinium Contrast Media Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 273. BRICS Gadolinium Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 274. G7 Gadolinium Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 275. G7 Gadolinium Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 276. G7 Gadolinium Contrast Media Market Size, by Ionic Linear, 2017-2032 (USD Million)
TABLE 277. G7 Gadolinium Contrast Media Market Size, by Nonionic Linear, 2017-2032 (USD Million)
TABLE 278. G7 Gadolinium Contrast Media Market Size, by Nonionic Macrocyclic, 2017-2032 (USD Million)
TABLE 279. G7 Gadolinium Contrast Media Market Size, by Form, 2017-2032 (USD Million)
TABLE 280. G7 Gadolinium Contrast Media Market Size, by Solution For Injection, 2017-2032 (USD Million)
TABLE 281. G7 Gadolinium Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 282. G7 Gadolinium Contrast Media Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 283. G7 Gadolinium Contrast Media Market Size, by Musculoskeletal, 2017-2032 (USD Million)
TABLE 284. G7 Gadolinium Contrast Media Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 285. G7 Gadolinium Contrast Media Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 286. G7 Gadolinium Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. G7 Gadolinium Contrast Media Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 288. G7 Gadolinium Contrast Media Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 289. G7 Gadolinium Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 290. NATO Gadolinium Contrast Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 291. NATO Gadolinium Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 292. NATO Gadolinium Contrast Media Market Size, by Ionic Linear, 2017-2032 (USD Million)
TABLE 293. NATO Gadolinium Contrast Media Market Size, by Nonionic Linear, 2017-2032 (USD Million)
TABLE 294. NATO Gadolinium Contrast Media Market Size, by Nonionic Macrocyclic, 2017-2032 (USD Million)
TABLE 295. NATO Gadolinium Contrast Media Market Size, by Form, 2017-2032 (USD Million)
TABLE 296. NATO Gadolinium Contrast Media Market Size, by Solution For Injection, 2017-2032 (USD Million)
TABLE 297. NATO Gadolinium Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 298. NATO Gadolinium Contrast Media Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 299. NATO Gadolinium Contrast Media Market Size, by Musculoskeletal, 2017-2032 (USD Million)
TABLE 300. NATO Gadolinium Contrast Media Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 301. NATO Gadolinium Contrast Media Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 302. NATO Gadolinium Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 303. NATO Gadolinium Contrast Media Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 304. NATO Gadolinium Contrast Media Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 305. NATO Gadolinium Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 306. Global Gadolinium Contrast Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 307. United States Gadolinium Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 308. United States Gadolinium Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 309. United States Gadolinium Contrast Media Market Size, by Ionic Linear, 2017-2032 (USD Million)
TABLE 310. United States Gadolinium Contrast Media Market Size, by Nonionic Linear, 2017-2032 (USD Million)
TABLE 311. United States Gadolinium Contrast Media Market Size, by Nonionic Macrocyclic, 2017-2032 (USD Million)
TABLE 312. United States Gadolinium Contrast Media Market Size, by Form, 2017-2032 (USD Million)
TABLE 313. United States Gadolinium Contrast Media Market Size, by Solution For Injection, 2017-2032 (USD Million)
TABLE 314. United States Gadolinium Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 315. United States Gadolinium Contrast Media Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 316. United States Gadolinium Contrast Media Market Size, by Musculoskeletal, 2017-2032 (USD Million)
TABLE 317. United States Gadolinium Contrast Media Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 318. United States Gadolinium Contrast Media Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 319. United States Gadolinium Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 320. United States Gadolinium Contrast Media Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 321. United States Gadolinium Contrast Media Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 322. United States Gadolinium Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 323. Canada Gadolinium Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 324. Canada Gadolinium Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 325. Canada Gadolinium Contrast Media Market Size, by Ionic Linear, 2017-2032 (USD Million)
TABLE 326. Canada Gadolinium Contrast Media Market Size, by Nonionic Linear, 2017-2032 (USD Million)
TABLE 327. Canada Gadolinium Contrast Media Market Size, by Nonionic Macrocyclic, 2017-2032 (USD Million)
TABLE 328. Canada Gadolinium Contrast Media Market Size, by Form, 2017-2032 (USD Million)
TABLE 329. Canada Gadolinium Contrast Media Market Size, by Solution For Injection, 2017-2032 (USD Million)
TABLE 330. Canada Gadolinium Contrast Media Market Size, by Application, 2017-2032 (USD Million)
TABLE 331. Canada Gadolinium Contrast Media Market Size, by Cardiovascular, 2017-2032 (USD Million)
TABLE 332. Canada Gadolinium Contrast Media Market Size, by Musculoskeletal, 2017-2032 (USD Million)
TABLE 333. Canada Gadolinium Contrast Media Market Size, by Neurology, 2017-2032 (USD Million)
TABLE 334. Canada Gadolinium Contrast Media Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 335. Canada Gadolinium Contrast Media Market Size, by End User, 2017-2032 (USD Million)
TABLE 336. Canada Gadolinium Contrast Media Market Size, by Ambulatory Care Centers, 2017-2032 (USD Million)
TABLE 337. Canada Gadolinium Contrast Media Market Size, by Diagnostic Imaging Centers, 2017-2032 (USD Million)
TABLE 338. Canada Gadolinium Contrast Media Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 339. Mexico Gadolinium Contrast Media Market Size, 2017-2032 (USD Million)
TABLE 340. Mexico Gadolinium Contrast Media Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 341. Mexico Gadolinium Contrast Media Market Size, by Ionic Linear, 2017-2032 (USD Million)
TABLE 342. Mexico Gadolinium Contrast Media Market Size, by Nonionic Linear, 2017-2032 (USD Million)
TABLE 343. Mexico Gadolinium Contrast Media Market Size, by Nonionic Macrocyclic, 2017-2032 (USD Million)
TABLE 344. Mexico Gadolinium Contrast Media Market Size, by Form, 2017-2032 (USD Million)
TABLE 345. Mexico Gadolinium Contrast Media Market Size, by Solution For Injection, 2017-2032 (USD Million)
TABLE

Companies Mentioned

  • Bayer AG
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Bracco Imaging S.p.A.
  • Canon Medical Systems Corporation
  • Daiichi Sankyo Company, Ltd.
  • GE HealthCare Technologies Inc.
  • Guerbet S.A.
  • Hengrui Medicine
  • iThera Medical
  • J.B. Chemicals and Pharmaceuticals Ltd.
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Lantheus Medical Imaging, Inc.
  • Mallinckrodt plc
  • Nanjing Jinling Pharmaceuticals
  • Nano Therapeutics Pvt. Ltd.
  • Shanghai Xudong Haipu Pharmaceutical Co., Ltd.
  • Siemens Healthineers
  • Subhra Pharma Pvt. Ltd.
  • United Imaging Healthcare
  • Zhejiang Hisun Pharmaceutical Co., Ltd.

Related Topics

Related Reports

High Purity Gadolinium Market - Global Forecast 2026-2032 - Product Image

High Purity Gadolinium Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Gadolinium-157 Market - Global Forecast 2026-2032 - Product Image

Gadolinium-157 Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Gadolinium-Based Contrast Agents Market Report 2026 - Product Image

Gadolinium-Based Contrast Agents Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Gadolinium Sputtering Target Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Gadolinium Sputtering Target Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Gadolinium Market Outlook 2026-2036 - Product Image

Gadolinium Market Outlook 2026-2036

  • Report
  • 348 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.